Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002

Archives of Dermatology

Volumn 143, Issue 7, 2007, Pages 854-859

  Criscione, Vincent D ^a   Weinstock, Martin A ^b  

^a PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CHILD; CUTANEOUS T CELL LYMPHOMA; EUROPEAN AMERICAN; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; REGISTRIES; SEER PROGRAM; SEX DISTRIBUTION; SKIN NEOPLASMS; UNITED STATES;

EID: 34447558598     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.7.854     Document Type: Article

References (22)

1. American Medical Association. Physician Characteristics and Distribution in the US: 2006 Edition. Chicago, IL: American Medical Association; 2006.
2. Holten VV, Percy C. Addendum to Conversion of Neoplasms by Topography and Morphology From the International Classification of Diseases for Oncology (ICD-O) (First Edition and Field Trials) to International Classification of Diseases for Oncology, Second Edition (ICD-0-2). Bethesda, MD: Surveillance Program, Division of Cancer Prevention and Control, National Cancer Institute; 1992.
3. Percy C, Fritz A, Ries L, eds. Conversion of Neoplasms by Topography and Morphology From the International Classification of Diseases for Oncology, Second Edition to International Classification of Diseases for Oncology, Third Edition. Bethesda, MD: Cancer Statistics Branch, Division of Cancer Control and Population Sciences, Surveillance Epidemiology and End Results Program, National Cancer Institute; 2001.
4. Weinstock MA, Horm JW. Mycosis fungoides in the United States: increasing incidence and descriptive epidemiology. JAMA. 1988;260(1):42-46.
5. Weinstock MA, Gardstein B. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality. Am J Public Health. 1999;89(8):1240-1244.
6. Merlino LA, Sullivan KJ, Whitaker DC, Lynch CF. The independent pathology laboratory as a reporting source for cutaneous melanoma incidence in Iowa, 1977-1994. J Am Acad Dermatol. 1997;37(4):578-585.
7. Bolognia JL, Headley A, Fine J, Berwick M. Histologic evaluation of pigmented lesions in Connecticut and its influence on the reporting of melanoma. J Am Acad Dermatol. 1992;26(2, pt 1):198-202.
8. Seiffert J. Stat bite - underreporting of melanoma. J Natl Cancer Inst. 1992;84(5):289.
9. Karagas MR, Thomas D, Roth GJ, Johnson LK, Weiss NS. The effects of changes in health care delivery on the reported incidence of cutaneous melanoma in western Washington State. Am J Epidemiol. 1991;133(1):58-62.
10. Health US. 2005 With Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics; 2005.
11. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst. 2002;94(20):1537-1545.
12. Morales MM, Olsen J, Johansen P, et al. Viral infection, atopy and mycosis fungoides: a European multicentre case-control study. Eur J Cancer. 2003;39(4):511-516.
13. Jumbou O, Mollat C, Guyen JMN, Billaudel S, Litoux P, Dreno B. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients. Br J Dermatol. 1997;136(2):212-216.
14. Zucker-Franklin D. The role of human T cell lymphotropic virus type I tax in the development of cutaneous T cell lymphoma. Ann N Y Acad Sci. September 2001;941:86-96.
15. Schmidt AN, Robbins JB, Greer JP, Zic JA. Conjugal transformed mycosis fungoides: the unknown role of viral infection and environmental exposures in the development of cutaneous T-cell lymphoma. J Am Acad Dermatol. 2006;54(5)(suppl):S202-S205.
16. Whittemore AS, Holly EA, Lee I-M, et al. Mycosis fungoides in relation to environmental exposures and immune response: a case-control study. J Natl Cancer Inst. 1989;81(20):1560-1567.
17. Morales-Suárez-Varela MM, Olsen J, Johansen P, et al. Occupational exposures and mycosis fungoides: a European multicentre case-control study (Europe). Cancer Causes Control. 2005;16(10):1253-1259.
18. Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst. 2002;94(16):1204-1210.
19. Weinstock MA. A registry-based case-control study of mycosis fungoides. Ann Epidemiol. 1991;1(6):533-539.
20. Biggar RJ, Horm J, Goedert JJ, Melbye M. Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984. Am J Epidemiol. 1987;126(4):578-586.
21. Biggar RJ, Horm J, Fraumeni JF, Greene MH, Goedert JJ. Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-1981. J Natl Cancer Inst. 1984;73(1):89-94.
22. Willemze R. Cutaneous T-cell lymphoma: epidemiology, etiology, and classification. Leuk Lymphoma. 2003;44(suppl 3):S49-S54.